Es gab 31 kürzliche Insider-Transaktionen für Intensity Therapeutics, Inc. (INTS), darunter 23 Käufe und 6 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $4.89M und die gesamten Insider-Verkäufe auf $1.78M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Bender Lewis H, Talamo Joseph, Wesolowski John M. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — INTS
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-03-26 |
Bender Lewis H |
President and CEO |
RSU-Zuteilung |
37,749 |
$6.11 |
$230.65K |
118,549 |
| 2025-12-31 |
Talamo Joseph |
Chief Financial Officer |
RSU-Zuteilung |
14,482 |
$0.26 |
$3.79K |
28,661 |
| 2025-12-31 |
Wesolowski John M |
Principal Accounting Officer |
RSU-Zuteilung |
8,918 |
$0.26 |
$2.34K |
85,354 |
| 2025-06-30 |
Talamo Joseph |
Chief Financial Officer |
RSU-Zuteilung |
14,179 |
$0.26 |
$3.7K |
14,179 |
| 2025-06-30 |
Wesolowski John M |
Principal Accounting Officer |
RSU-Zuteilung |
69,745 |
$0.26 |
$18.2K |
76,436 |
| 2025-05-02 |
Dubin Thomas I H |
Director |
RSU-Zuteilung |
50,000 |
$0.57 |
$28.5K |
50,000 |
| 2025-05-02 |
Bender Lewis H |
10 Percent Owner, Officer: President and CEO |
RSU-Zuteilung |
700,000 |
$0.57 |
$399K |
700,000 |
| 2025-05-02 |
Goldberg Mark A |
Director |
RSU-Zuteilung |
50,000 |
$0.57 |
$28.5K |
50,000 |
| 2025-05-02 |
Talamo Joseph |
Chief Financial Officer |
RSU-Zuteilung |
300,000 |
$0.57 |
$171K |
300,000 |
| 2025-05-02 |
Leahy Emer |
Director |
RSU-Zuteilung |
50,000 |
$0.57 |
$28.5K |
50,000 |
| 2025-05-02 |
Wesolowski John M |
Principal Accounting Officer |
RSU-Zuteilung |
100,000 |
$0.57 |
$57K |
100,000 |
| 2025-05-02 |
Donovan Daniel |
Director |
RSU-Zuteilung |
50,000 |
$0.57 |
$28.5K |
50,000 |
| 2024-10-21 |
Talamo Joseph |
Chief Financial Officer |
RSU-Zuteilung |
427,379 |
$3.44 |
$1.47M |
427,379 |
| 2024-10-21 |
Wesolowski John M |
Principal Accounting Officer |
RSU-Zuteilung |
70,028 |
$3.44 |
$240.9K |
70,028 |
| 2024-06-05 |
Wesolowski John M |
Principal Accounting Officer |
Optionsausübung |
1,000 |
$4.00 |
$4K |
6,691 |
| 2024-05-14 |
Dubin Thomas I H |
Director |
Unbekannt |
- |
- |
- |
- |
| 2024-05-14 |
Dubin Thomas I H |
Director |
RSU-Zuteilung |
50,000 |
$4.42 |
$221K |
50,000 |
| 2024-03-06 |
Bender Lewis H |
10 Percent Owner, Officer: President and CEO |
RSU-Zuteilung |
33,574 |
$5.19 |
$174.25K |
33,574 |
| 2024-03-06 |
Goldberg Mark A |
Director |
RSU-Zuteilung |
50,000 |
$5.19 |
$259.5K |
50,000 |
| 2024-03-06 |
Leahy Emer |
Director |
RSU-Zuteilung |
50,000 |
$5.19 |
$259.5K |
50,000 |
| 2024-03-06 |
Wesolowski John M |
See Remarks |
RSU-Zuteilung |
25,000 |
$5.19 |
$129.75K |
25,000 |
| 2024-03-06 |
Donovan Daniel |
Director |
RSU-Zuteilung |
50,000 |
$5.19 |
$259.5K |
50,000 |
| 2023-12-11 |
Talamo Joseph |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2023-12-11 |
Talamo Joseph |
Chief Financial Officer |
RSU-Zuteilung |
80,000 |
$6.88 |
$550.4K |
80,000 |
| 2023-07-19 |
Wesolowski John M |
Interim CFO |
RSU-Zuteilung |
50,000 |
$6.43 |
$321.5K |
50,000 |
| 2023-06-29 |
Bender Lewis H |
10 Percent Owner, Officer: President and CEO |
Veräußerung |
75,000 |
$11.50 |
$862.5K |
- |
| 2023-06-29 |
Goldberg Mark A |
Director |
Veräußerung |
25,000 |
$11.50 |
$287.5K |
- |
| 2023-06-29 |
Ahlers James M |
Executive VP of Cf |
Veräußerung |
5,000 |
$9.00 |
$45K |
- |
| 2023-06-29 |
Leahy Emer |
Director |
Veräußerung |
25,000 |
$11.50 |
$287.5K |
- |
| 2023-06-29 |
Wesolowski John M |
Interim CFO |
Veräußerung |
6,500 |
$11.50 |
$74.75K |
- |
| 2023-06-29 |
Donovan Daniel |
Director |
Veräußerung |
25,000 |
$9.00 |
$225K |
- |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
